Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07254624 · ClinicalTrials.gov registry record · NA

Pilot Assessment of Continuous Glucose Monitor for Post-meal Glucose Responses to Herbs and Spices.

A NA study of Post-prandial Glucose Response, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07254624: Recruiting NA study of Post-prandial Glucose Response, sponsored by University of Alabama at Birmingham.

NCT07254624 is a NA study of Post-prandial Glucose Response that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07254624, a NA study of Post-prandial Glucose Response, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether continuous glucose monitoring is sensitive to quantifying the glucose response related to consumption of a starchy vegetable (potato) in combination with or separate from consumption of herbs and spices at the same meal.

Primary Outcome

Glucose response will be measured using continuous glucose monitors. These devices will capture changes in glucose response from the start of the meal to about 2 hours postprandial.

Interventions

  • OTHER Mix of five herbs and spices
  • OTHER Potato entree

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-03-16
Est. Completion 2027-11
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT07254624 shows while recruiting

NCT07254624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Post-prandial Glucose Response appearing as the primary indexed condition, and to 2 interventions - of which Mix of five herbs and spices is the first listed.

NCT07254624 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT07254624 about?

NCT07254624 is a clinical study titled "Pilot Assessment of Continuous Glucose Monitor for Post-meal Glucose Responses to Herbs and Spices.". The purpose of this study is to determine whether continuous glucose monitoring is sensitive to quantifying the glucose response related to consumption of a starchy vegetable (potato) in combination with or separate from consumption of herbs and spices at the same meal.

What is the current status of trial NCT07254624?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-03-16. Estimated completion is 2027-11.

What conditions does trial NCT07254624 study?

This clinical trial studies the following conditions: Post-prandial Glucose Response.

What interventions are being tested in trial NCT07254624?

The interventions under investigation include: Mix of five herbs and spices (OTHER), Potato entree (OTHER).

Who is sponsoring clinical trial NCT07254624?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07254624 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07254624's enrollment target sits among peer trials

10 1928th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07254624, the US trial registry maintained by the National Library of Medicine. NCT07254624 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.